The effects of acute and chronic haloperidol treatment on dopamine release mediated by the medial forebrain bundle in the striatum and nucleus accumbens

Neuropsychopharmacology

Volumn 14, Issue 3, 1996, Pages 211-223

  Egan, Michael F ^a   Chrapusta, Stanislaw J ^a   Karoum, Farouk ^a   Wyatt, Richard Jed ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

3 Methoxytyramine; Depolarization inactivation; Dopamine; Haloperidol; Mesolimbic; Neuroleptic; Nigrostriatal; Psychosis

Indexed keywords

3 O METHYLDOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; PARGYLINE; TETRODOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; MALE; MEDIAL FOREBRAIN BUNDLE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 0030000513     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00111-P     Document Type: Article

References (71)

1. Armstrong CM (1981): Sodium channels and gating currents. Physiol Rev 66(3):644-683
2. Altar A, Neve K, Loughlin SE, Marshall JF, Fallon JH (1983): The crossed mesostriatal projection: Neurochemistry and developmental response to lesion. Brain Res 279:1-8
3. Bettini E, Ceci A, Spinelli R, Samanin R (1987): Neuroleptic-like effects of the 1-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochem Pharmacol 36:2387-2391
4. Blaha CD, Lane RF (1987): Chronic treatment with classical and atypical antipsychoric drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Neurosci Lett 78:199-204
5. Brown EE, Damsma G, Gumming P, Fibiger HC (1991): Interstitial 3-methoxytyramine reflects striatal dopamine release: An in vivo microdialysis study. J Neurochem 57(2):701-707
6. Bunney BS, Grace AA (1978): Acute and chronic haloperdiol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728
7. Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott (1990): Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. J Neurochem 55(3):981-988
8. Catterall WA (1980): Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Ann Rev Pharmacol Toxicol 20:15-43
9. Carr VJ (1983): Recovery from schizophrenia: A review of patterns of psychosis. Schizophr Bull 9:95-121.
10. Cenci MA, Kalen P, Mandel RJ, Bjorklund A (1992): Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: A microdialysis study in the rat. Brain Res 581:217-228.
11. Chen J, Paredes W, Gardner EL (1991): Chronic treatment with clozapine selectively decreases basal dopamine release in nucleus accumbens but not in caudate-putamen as measured by in vivo microdialysis: Further evidence for depolarization block. Neurosci Lett 122:127-131
12. Chiodo LA, BS Bunney (1983): Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A-9 and A-10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619
13. Chiodo LA, Bunney BS (1985): Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2538-2544
14. Chiodo LA, Bunney BS (1987): Population response of midbrain dopaminegic neurons to neuroleptics: Further studies on time course and nondopaminergic neuronal influences. J Neurosci 7:629-633
15. Chrapusta SJ, Karoum F, Egan MF, Wyatt RJ (1994): Evidence for impulse flow-independent dopamine release, and their relationship to dopamine metabolism in three rat brain regions. Eur J Pharmacol 655:271-275
16. Chrapusta SJ, Egan MF, Karoum F, Wyatt RJ (1995): Regional effects of general anesthetics on dopamine release in rat brain: A 3-methoxytyramine study. Brain Res (in press)
17. Commisiong JW, Slimovitch C, Toffano G. (1990): Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br J Pharmacol 99:741-749
18. Compton DR, Johnson KM (1989): Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accuumbens. J Pharmacol Exp Ther 248:521-536
19. Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacologic potencies of antischizophrenic drugs. Science 192:481-483
20. Demarest KT and Moore KE (1979): Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular, and tuberohypophyseal neurons. J Neural Transm 46:263-277
21. Egan MF, Karoum F, Wyatt RJ (1991): Effects of acute and chronic clozapine and haloperidol administration on 3-methoxytyramine accumulation in rat prefrontal cortex, nucleus accumbens, and striatum. Eur J Pharmacol 199:191-199
22. Egan MF, Chrapusta SJ, Karoum FK, Wyatt RJ (1993): Evidence against the depolarization block hypothesis of the mechanism of action of antipsychotic drugs: Effects of tetrodotoxin infusion into the median forebrain bundle after acute and chronic dopamine release. Schizophr Res 9:218
23. Glovinsky D, Kirch DG, Wyatt RJ (1992): Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients. Biol Psychiatry 31:968-970
24. Grace AA (1991): Plastic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophremia. Neuroscience 41(1):1-24
25. Grace AA (1992): The depolarization block hypothesis of neuroleptic action: Implications for the etiology and treatment of schizophrenia. J Neural Transm 36(suppl):91-131
26. Grace AA, Bunney BS (1986): Induction of depolarization block in midbrain dopaminergic neurons by repeated admimistration of haloperidol: Analysis using in vivo intracellular recording. J Pharmacol Exp Therap 238: 1092-1100
27. Gonon FG (1988): Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24(1):19-28
28. Hernandez L, Hoebel B (1989): Haloperidol given chronically decreases basal dopamine in the prefrontal cortex more than the striatum or nucleus accumbens as simultaneously measured by microdialysis. Brain Res Bull 22:763-769
29. Hollerman JR, Grace AA (1989): Acute haloperidol administration induces depolarization block of nigral dopamine neurons in rats after partial dopamine lesions. Neurosci Lett 96:82-88
30. Hollerman JR, Abercrombie ED, Grace AA (1992): Electrophysiologic, biochemical, and behavioral studies of acute and haloperidol-induced depolarization block of nigral dopamine neurons. Neuroscience 47(3)589-601
31. Ichikawa J, Meltzer HY (1990): The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Eur J Pharmacol 176:371-374
32. Imperato A, DiChiarra G (1985): Dopamine release and metabolism in awake rats as studied by transstriatal dialysis. J Neurosci 5:297-306
33. Invernizzi R, Morali F, Possi L, Samanin R (1990): Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Br J Pharmacol 99:741-749
34. Kalivas PW and Duffy P (1991): A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem 56:961-967
35. Karoum F, Egan MF (1992): Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: A comparison of acute clozapine and haloperidol. Br J Pharmacol 105:703-707
36. Karoum F, Chrapusta SJ, Egan MF (1994a): 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: Reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two-pool model. J Neurochem 63(3):972-979
37. Karoum F, Chrapusta SJ, Brinjak R, Hitri A, Wyatt RJ (1994b): Regional effects of amphetamine, cocaine, nomifensine, and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Br J Pharmacol 113: 1391-1399
38. Keck PE, Cohen BM, Baldessarini RJ, McElroy SL (1989): Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry 146:1289-1292
39. Keefe KA, Zigmond MJ, Abercrombie ED (1992): Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience 47:325-332
40. Keefe KA, Sved AF, Zigmond MJ, Abercrombie ED (1993): Stress-induced dopamine release in the neostriatum: Evaluation of the role of action potentials in nigrostriatal dopamine neurons or local infiltration by endogenous excitatory amino acids. J Neurochem 61:1943-1952
41. Keller RW, Stricker EM, Zigmond MJ (1983): Environmental stimuli but not homeostatic challenges produce apparent increases in dopaminergic activity in the striatum: An analysis by in vivo voltammentry. Brain Res 279: 159-170
42. Kuczenski R, Segal DS (1992): Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J Pharmacol Exp Ther 262: 1085-1094
43. Lane RF, Blaha CD (1987): Chronic haloperidol decreases dopamine release in striatum and nucleus accumbens in vivo: Depolarization block as a possible mechanism of action. Brain Res Bull 18:135-142
44. Lookingland KJ, Moore KE (1984): Dopamine receptor-mediated regulation of incertohypothalamic dopaminergic neurons in the male rat. Brain Res 304:329-338
45. Loughlin SE, Fallon JH (1982): Mesostriatal projections from ventral tegmentum and dorsal raphe: Cells project ipsilaterally or contralaterally but not bilaterally. Neurosci Lett 32:11-16
46. Meyers RD (1972): Methods for chemical stimulation of the brain. In Meyers RD (ed), Methods in Psychobiology. New York, Academic Press, pp 247-279
47. Moghaddam B, Bunney BS (1993): Depolarization inactivation of dopamine neurons: Terminal release characteristics. Synapse 14:195-200
48. Moore KE (1987): Hypothalamic dopaminergic neuronal systems. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York, Raven Press, pp 127-139
49. Miu P, Karoum F, Toffano G, Commisiong JW (1992): Regulatory aspects of nigrostriatal dopamine neurons. Exp Brain Res 91:489-495
50. Narahashi T (1974): Chemicals as tools in the study of excitable membranes. Physiol Rev 54(4):813-877
51. Osborne PG, O'Connor WT, Drew KL, Ungerstedt U (1990): An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anesthetized rats. J Neurosci Methods 34:99-105
52. Paxinos G, Watson C (1986): The Rat Brain in Stereotaxic Coordinates, 2nd ed. New York, Academic Press.
53. Robinson TE, Whishaw IQ (1988): Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesions of the substantia nigra: A microdialysis study in freely moving rats. Brain Res 450:209-224
54. Romo R, Cheramy A, Godeheu G, Glowinski J (1986): In vivo presynaptic control of dopamine release in the cat caudate nucleus-I. Opposite changes in neuronal activity and release evoked from thalamic motor nuclei. Neuroscience 19:1067-1079
55. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylene-dioxymethamphetamine. J Neurochem 62:1382-1389
56. See RE, Chapman MA, Meshul CK (1992): Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse 12:147-154
57. + channel currents observed in cultured rat muscle cells. Nature 287:447-449
58. Skarsfeldt T (1988): Differential effects after repeated treatment with haloperidol, clozapine, thioridazine, and tefludazine on SNC and VTA dopamine neurones in rats. Life Sci 42:1037-1044
59. Stern RG, Kahn RS, Harvey PD, Amin F, Apter SH, Hirschowitz J (1993): Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res 10(2):165-171
60. Tanaka T, Vincent SR, Nomikos GG, Fibiger HC (1992): Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum. J Neurochem 59:1640-1645
61. Tepper JM, Creese I, Schwartz DH (1991): Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis. Brain Res 534:283-292
62. Westerink BHC, De Vries JB (1988): Characterization of in vivo dopamine release as determined by brian microdialysis after acute and subchronic implantations: Methodologic aspects. J Neurochem 51:683-687
63. White FJ, Wang RX (1983a): Comparison of the effects of chronic haloperidol treatment on A-9 and A-10 dopaminergic neurons in the rat. Life Sci 32:983-993
64. White FJ, Wang RX (1983b): Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057
65. Wood PL, Kim HS, Marien MR (1987): Intracerebral dialysis: Direct evidence for the utility of 3-MT measurements as an index of dopamine release. Life Sci 41:1-9
66. Wood PL, Altar CA (1988): Dopamine release in vivo from nigrostriatal mesolimbic and mesocortical neurons: Utility of 3-methoxytyramine measurements. Pharmacol Rev 4:163-187
67. Wood PL, Kim HS, Stocklin K, Rao TS (1988): Dynamics of the striatal 3-MT pool in rat and mouse: Species differences as assessed by steady-state measurements and intracerebral dialysis. Life Sci 42:2275-2281
68. Zetterstrom T, Sharp T, Ungerstedt U (1985): Effect of neuroleptic drug on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 106:27-37
69. Zhang W, Tilson H, Stachowiak MK, Hong JS (1989): Repeated haloperidol changes basal release of striatal dopamine and subsequent response to haloperidol challenge. Brain Res 484:389-392
70. Zigmond MJ, Berger TW, Grace AA, Stricker EM (1989): Compensatory responses to nigrostriatal bundle injury: Studies with 6-hydroxydopamine in an animal model of Parkinson. Mol Chem Neuropathol 10:185-200
71. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM (1990): Compensation after lesions of central dopaminergic neurons. Some clinical and basic implications. TINS 13(7):290-295